Sent from my iPhone Begin forwarded message:

From: Antitsa Stoycheva <astoycheva@aliosbiopharma.com> Date: June 16, 2015 at 3:49:39 PM PDT To: "agard@msg.ucsf.edu" <agard@msg.ucsf.edu>, "nadav.ahituv@ucsf.edu" <nadav.ahituv@ucsf.edu>, "steven.altschuler@ucsf.edu" <steven.altschuler@ucsf.edu>, "babbitt@cgl.ucsf.edu" <babbitt@cgl.ucsf.edu>, "bandyopadhyays@cc.ucsf.edu" <bandyopadhyays@cc.ucsf.edu>, "sebaran@cgl.ucsf.edu" <sebaran@cgl.ucsf.edu>, "brenner@compbio.berkeley.edu" <brenner@compbio.berkeley.edu>, "atul.butte@ucsf.edu" <atul.butte@ucsf.edu>, "bconklin@gladstone.ucsf.edu" <bconklin@gladstone.ucsf.edu>, "joe@derisilab.ucsf.edu" <joe@derisilab.ucsf.edu>, "hana.el-samad@ucsf.edu" <hana.el-samad@ucsf.edu>, "tef@cgl.ucsf.edu" <tef@cgl.ucsf.edu>, "fischbach@fischbachgroup.org" <fischbach@fischbachgroup.org>, "kathy.giacomini@ucsf.edu" <kathy.giacomini@ucsf.edu>, "ryan.hernandez@ucsf.edu" <ryan.hernandez@ucsf.edu>, "matt@cgl.ucsf.edu" <matt@cgl.ucsf.edu>, "ajain@jainlab.org" <ajain@jainlab.org>, "ajohnson@cgl.ucsf.edu" <ajohnson@cgl.ucsf.edu>, "michael.keiser@ucsf.edu" <michael.keiser@ucsf.edu>, "kortemme@cgl.ucsf.edu" <kortemme@cgl.ucsf.edu>, "nevan.krogan@ucsf.edu" <nevan.krogan@ucsf.edu>, "haoli@genome.ucsf.edu" <haoli@genome.ucsf.edu>, "lim@cmp.ucsf.edu" <lim@cmp.ucsf.edu>, "hitenmadhani@gmail.com" <hitenmadhani@gmail.com>, "mmcmanus@diabetes.ucsf.edu" <mmcmanus@diabetes.ucsf.edu>, "kpollard@gladstone.ucsf.edu" <kpollard@gladstone.ucsf.edu>, "rischn@humgen.ucsf.edu" <rischn@humgen.ucsf.edu>, "sali@salilab.org" <sali@salilab.org>, "mark@biostat.ucsf.edu" <mark@biostat.ucsf.edu>, "mark.seielstad@ucsf.edu" <mark.seielstad@ucsf.edu>, "sen@biostat.ucsf.edu" <sen@biostat.ucsf.edu>, "bshoichet@gmail.com" <bshoichet@gmail.com>, "peter.turnbaugh@ucsf.edu" <peter.turnbaugh@ucsf.edu>, "wallj@humgen.ucsf.edu" <wallj@humgen.ucsf.edu>, "leor.weinberger@gladstone.ucsf.edu" <leor.weinberger@gladstone.ucsf.edu>, "weissman@cmp.ucsf.edu" <weissman@cmp.ucsf.edu>, "wittej@humgen.ucsf.edu" <wittej@humgen.ucsf.edu>, "lani.wu@ucsf.edu" <lani.wu@ucsf.edu>, "jimmie.ye@ucsf.edu" <jimmie.ye@ucsf.edu>, "noah.zaitlen@ucsf.edu" <noah.zaitlen@ucsf.edu> Cc: Antitsa Stoycheva <astoycheva@aliosbiopharma.com> Subject: Bioinformatics job opening: please post

Dear Bioinformatics Faculty at UCSF,

Alios BioPharma, Inc., a Johnson & Johnson company, is recruiting for an entry Ph. D. level bioinformatics job opening. This is an excellent opportunity for a Ph. D. scientist with 2+ years of relevant post-doctoral experience who seeks to join a dynamic interdisciplinary team of dedicated researchers in a biotech setting.

Would you please forward the attached announcement to qualified candidates who might be interested in this opportunity? We’d like to reach as many outstanding applicants as possible, so please feel free to pass on to other research groups.

With appreciation, Antitsa Stoycheva

Antitsa D. Stoycheva, Ph. D. Group Leader, Computational Chemistry & Bioinformatics Alios BioPharma 260 E. Grand Ave., 2nd Floor South San Francisco, CA 94080 astoycheva@aliosbiopharma.com Phone: (650) 635-5513 Fax: (650) 872-0584

Job description follows:

Scientist/Senior Scientist, Bioinformatics Description Alios BioPharma, Inc, a member of Johnson & Johnson's Family of Companies, is recruiting for a Scientist/Senior Scientist, Bioinformatics to be located in South San Francisco, CA.

Alios BioPharma, Inc of Johnson & Johnson are dedicated to addressing and solving the most important unmet medical needs of our time, including in oncology, immunology, neuroscience, infectious disease, and cardiovascular and metabolic diseases. Driven by our commitment to patients, we develop sustainable, integrated healthcare solutions by working side-by-side with healthcare stakeholders, based on partnerships of trust and transparency.

Thriving on a diverse company culture, celebrating the uniqueness of our employees and committed to inclusion. Proud to be an equal opportunity employer. Summary/Scope: We seek an exceptional candidate to join the Computational Chemistry and Bioinformatics group at Alios BioPharma. The candidate must be a highly motivated self-starter and team player who performs well in a fast-paced, multidisciplinary team environment. The candidate will report to the Group Leader, Computational Chemistry and Bioinformatics, and their main responsibility will be to conduct a comprehensive scope of bioinformatics and computational activities supporting discovery and development stage oligonucleotide therapeutics projects. Hands-on experience with data mining, sequence processing, in silico design, structure prediction and free energy calculation for nucleic acid constructs is required. Expert knowledge of Unix/Linux, Perl/Python, vi, sed, object-oriented programming language(s), leading-edge software packages relevant to the nucleic acids field, as well as the ability to create custom code to address specific research tasks is a must. Experience with database management, SQL, and Linux system administration is a plus. Advanced understanding of biological pathways relevant to oligonucleotide therapeutics is highly desirable. Ability to initiate and carry out project-driven research with minimal supervision, as well as accomplished communication skills, including clear and efficient presentation of their own work to a diverse group of experts is required. Proven productivity track record in an academic or industrial setting is expected.

Qualifications:

Ph.D. in bioinformatics/cheminformatics, theoretical or computational chemistry, or a related field with 2+ years of relevant post-doctoral experience in an academic or industrial setting is required. Publication/patent record backing up a productive research track is a definite plus.

This message (including any attachments) is intended only for the use of the individual or entity to which it is addressed and may contain information that is non-public, proprietary, privileged, confidential, and exempt from disclosure under applicable law or may constitute as attorney work product. If you are not the intended recipient, you are hereby notified that any use, dissemination, distribution, or copying of this communication is strictly prohibited. If you have received this communication in error, notify us immediately by telephone (650-635-5500) or delete this message immediately. Thank you.